ArticleEuropean heart journal. Digital health2026
Development and validation of clinical prediction models for personalized renal function monitoring in people with heart failure in primary care: the RENAL-HF study protocol.
Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Heart failure (HF) is a growing problem in society with an ageing population and many patients with heart failure are affected by renal dysfunction. The RENAL-HF project aims to develop predictive risk models to support personalized renal function monitoring and treatment in patients with HF in primary care. Methods and results: This study will use electronic health records from the Clinical Practice Research Datalink (CPRD) database for patients who were diagnosed with HF. We will develop three prediction models-Mixed-effects model, Growth mixture model, and recurrent neural network-long short-term memory model to predict future worsening renal function, including events that lead to hospitalization, and death. Using an internal-external validation approach based on geographic region, we will choose the top-performing model using various metrics to evaluate the predictive performance. Conclusion: This protocol provides a detailed description of the methods used for developing and validating prognostic models for personalized renal function monitoring in people with HF in primary care. Protocol registration: The study and use of CPRD data were approved by the Independent Scientific Advisory Committee for Clinical Practice Research Datalink research (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.